Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2001 Mar 27;98(7):3641-3.
doi: 10.1073/pnas.081082498.

Uncoupling fibroblast growth factor receptor 2 ligand binding specificity leads to Apert syndrome-like phenotypes

Affiliations
Comment

Uncoupling fibroblast growth factor receptor 2 ligand binding specificity leads to Apert syndrome-like phenotypes

K Yu et al. Proc Natl Acad Sci U S A. .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
FGF signaling pathways in limb development. (A) Structure of the FGFR showing three disulfide linked (s-s) Ig loops (I, II, III), a transmembrane domain (TM) and an intracellular tyrosine kinase domain (TK). The striped region in the carboxyl- terminal half of Ig loop III is subject to alternative utilization of either exon b or exon c. These correspond to exons 8 and 9 of the Fgfr2 gene. (B) Schematic diagram of a developing limb showing the apical ectodermal ridge (AER), distal mesenchyme (DM), mesenchyme, and mesenchymal condensation. Sites of Fgf and Fgfr expression are shown. Limb bud initiation and outgrowth is regulated by a reciprocal signaling loop in which FGF10 signals to FGFR2b and FGFs 4, 8, 9, and 17 signal to FGFR1c (solid arrows). FGFR2c is prominently expressed in the mesenchymal condensation; however, its function and endogenous ligand in this location is not known. (C) Missense mutations causing AS could allow autocrine/juxtacrine activation of FGFR2 in the mesenchymal condensation and in the AER (dashed arrows). (D) Alu element insertions and the hemizygous deletion of exon c allow FGFR2b expression in mesenchymal tissue, effectively mimicking the missense mutations by allowing ectopic receptor activation by ligands such as FGF7 (dashed arrow).

Comment on

References

    1. Naski M C, Ornitz D M. Front Biosci. 1998;3:D781–D794. - PubMed
    1. Muenke M, Schell U. Trends Genet. 1995;11:308–313. - PubMed
    1. Wilkie A O M, Morriss-Kay G M, Jones E Y, Heath J K. Curr Biol. 1995;5:500–507. - PubMed
    1. Hajihosseini M K, Wilson S I, DeMoerlooze L, Dickson C. Proc Natl Acad Sci USA. 2001;98:3855–3860. - PMC - PubMed
    1. Szebenyi G, Fallon J F. Int Rev Cyt. 1999;185:45–106. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources